Evidence map›Paper›PMID 29721166›Full record

ArticleOncotarget2018

Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFR

Florian Lüke, Raquel Blazquez, Rezan Fahrioglu Yamaci, Xin Lu, Benedikt Pregler, Stefan Hannus, Karin Menhart, Dirk Hellwig, Hans-Jürgen Wester, Saskia Kropf and 12 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Study of the co-expression gene modules of non-small cell lung cancer metastases.Cancer biomarkers : section A of Disease markers · 2021
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Florian LükeDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Raquel BlazquezDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Rezan Fahrioglu YamaciChair of Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Xin LuChair of Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Benedikt PreglerInstitute of Radiology, University Hospital Regensburg, Regensburg, Germany.
Stefan HannusIntana Bioscience GmbH, Martinsried, Germany.
Karin MenhartDepartment of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Dirk HellwigDepartment of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Hans-Jürgen WesterChair of Pharmaceutical Radiochemistry, Technische Universität München, Munich, Germany.
Saskia KropfSCINTOMICS GmbH, Fuerstenfeldbruck, Germany.
Daniel HeudoblerDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Jirka GrosseDepartment of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Jutta MoosbauerDepartment of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
Markus HuttererDepartment of Neurology, University Hospital Regensburg, Regensburg, Germany.
Peter HauDepartment of Neurology, University Hospital Regensburg, Regensburg, Germany.
Markus J RiemenschneiderDepartment of Neuropathology, University Hospital Regensburg, Regensburg, Germany.
Michaela BayerlováUniversity Medical Center Göttingen, Department of Medical Statistics, Göttingen, Germany.
Annalen BleckmannUniversity Medical Center Göttingen, Department of Medical Statistics, Göttingen, Germany.
Bernhard PolzerDivision Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.
Tim BeißbarthUniversity Medical Center Göttingen, Department of Medical Statistics, Göttingen, Germany.
Christoph A KleinChair of Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
Tobias PukropDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
University Hospital Regensburg · DEUniversitätsmedizin Göttingen · DEUniversity of Regensburg · DEFraunhofer Institute for Toxicology and Experimental Medicine · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain and leptomeningeal metastasis (LMM) of non-small cell lung cancer is still associated with poor prognosis. Moreover, the current diagnostic standard for LMM often yields false negative results and the scientific progress in this field is still unsatisfying. We present a case of a 71-year old patient with an isolated LMM. While standard diagnostics could only diagnose a cancer of unknown primary, the use of [

Indexed as

brain metastasisCXCR4fluorescence cross correlation spectroscopyNSCLCpentixafor PET/CT

Identifiers

PMID29721166
PMCPMC5922360
OpenAlexW2798206107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.